Latest News for: ibd
Edit
From research to remission: communication interventions are transforming IBD care for nearly 1,000 patients across China and the US (Hong Kong Baptist University)
Public Technologies 09 Oct 2026
) BACK Inflammatory bowel disease (IBD) affects millions worldwide, with cases rising rapidly in China ... [...]. This is an abstract of the document ... Attachments Original document Permalink.
Edit
Gastro Health Announces Dr. Maria T. Abreu as New Sr. Vice President of IBD Clinical Care and Innovation (Gastro Health LLC)
Public Technologies 09 Oct 2026
Vice President of IBD Clinical Care and Innovation ... Widjaja IBD Institute at Cedars-Sinai Medical Center, and more than a decade as Director of the Crohn's & Colitis Center at the University of Miami School of Medicine.
Edit
Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara's Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD
PR Newswire 09 Oct 2026
Edit
Prifemilast Demonstrates Superior Efficacy vs. Apremilast in Newsoara’s Head-to-Head Phase 3 Psoriasis Trial; cAMPfield Advancing the Potential Best-in-Class Oral PDE4 Inhibitor in IBD (cAMPfield Therapeutics Inc)
Public Technologies 09 Oct 2026
We are grateful to Newsoara and to the investigators and patients who made these trials possible, and we look forward to building on these results for patients living with IBD." Bill Gerhart, Chief Executive Officer, cAMPfield Therapeutics.
Edit
NIH Awards Mount Sinai Researcher $3.3 Million to Study How “Forever Chemicals” May Contribute to IBD (Mount Sinai Health System Inc)
Public Technologies 06 Oct 2026
Edit
The one travel concern many people are too embarrassed to discuss
Azcentral 06 Oct 2026
Most of us can hold it until we find the nearest restroom, but people with inflammatory bowel disease (IBD) and other medical conditions don’t always have a choice.
Edit
'We can't wait': When restroom access is a critical need
Usatoday 05 Oct 2026
Most of us can hold it until we find the nearest restroom, but people with inflammatory bowel disease (IBD) and other medical conditions don’t always have a choice.
Edit
Crohn’s and Colitis Canada Invests $1.5 Million to Advance IBD Research and Future Care
Nasdaq Globe Newswire 01 Oct 2026
Edit
Palisade Bio Receives FDA Clearance of IND for PALI-2108 in Crohn's Disease, Expanding Phase 2 Development Across IBD (Palisade Bio Inc)
Public Technologies 22 Sep 2026
). The text version of this document is not available ... Disclaimer ... (noodl. 134631711) .
Edit
Celltrion USA and Prometheus Laboratories Inc. Announce Sponsored Testing Collaboration on Anser IFX for ZYMFENTRA (infliximab-dyyb)
ACCESSWIRE 06 Jul 2026
Celltrion Testing Access Program Expands Availability of Therapeutic Drug Monitoring to Support Patient Transition to Subcutaneous Infliximab ... About Celltrion USA. Celltrion USA is Celltrion's U.S. subsidiary established in 2018 ... patients ... patents ... ... ....
- 1